Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$127.73 - $147.2 $4.33 Million - $4.99 Million
-33,913 Closed
0 $0
Q4 2023

Feb 13, 2024

SELL
$92.79 - $142.53 $473 Million - $726 Million
-5,092,701 Reduced 99.34%
33,913 $4.72 Million
Q3 2023

Nov 13, 2023

BUY
$128.91 - $192.44 $3.76 Million - $5.61 Million
29,153 Added 0.57%
5,126,614 $704 Million
Q2 2023

Aug 11, 2023

BUY
$183.43 - $232.67 $2.75 Million - $3.49 Million
14,983 Added 0.29%
5,097,461 $956 Million
Q1 2023

May 11, 2023

BUY
$193.75 - $232.55 $6.6 Million - $7.92 Million
34,076 Added 0.67%
5,082,478 $1.18 Billion
Q4 2022

Feb 13, 2023

BUY
$187.24 - $242.74 $98.7 Million - $128 Million
527,005 Added 11.66%
5,048,402 $1.02 Billion
Q3 2022

Nov 04, 2022

BUY
$177.23 - $227.44 $307 Million - $394 Million
1,731,169 Added 62.04%
4,521,397 $863 Million
Q2 2022

Aug 10, 2022

BUY
$181.58 - $368.0 $28.9 Million - $58.5 Million
159,057 Added 6.05%
2,790,228 $514 Million
Q1 2022

May 12, 2022

SELL
$303.87 - $423.8 $9.58 Million - $13.4 Million
-31,531 Reduced 1.18%
2,631,171 $919 Million
Q4 2021

Feb 11, 2022

BUY
$347.28 - $421.83 $44 Million - $53.4 Million
126,623 Added 4.99%
2,662,702 $1.01 Billion
Q3 2021

Nov 10, 2021

BUY
$405.61 - $524.84 $22.4 Million - $29 Million
55,303 Added 2.23%
2,536,079 $1.03 Billion
Q2 2021

Aug 12, 2021

BUY
$372.84 - $481.5 $38.7 Million - $50 Million
103,747 Added 4.36%
2,480,776 $1.17 Billion
Q1 2021

May 12, 2021

BUY
$361.28 - $504.76 $17.6 Million - $24.6 Million
48,751 Added 2.09%
2,377,029 $913 Million
Q4 2020

Feb 11, 2021

BUY
$292.7 - $370.96 $517 Million - $655 Million
1,765,503 Added 313.71%
2,328,278 $861 Million
Q3 2020

Nov 12, 2020

BUY
$268.51 - $400.74 $151 Million - $226 Million
562,775 New
562,775 $174 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.4B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track Polen Capital's Portfolio

Track Polen Capital Portfolio

Follow Polen Capital (Polen Capital Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polen Capital Management LLC and Polen Capital with notifications on news.